Probiotics & Postbiotics

Probiotics, prebiotics, postbiotics and synbiotics are reshaping functional foods with strain-specific evidence requirements. The session covers next-generation probiotics (Akkermansia muciniphila, Faecalibacterium prausnitzii) and clinical-trial activity, postbiotics and bacterial metabolites including butyrate and acetate, strain-specific efficacy evidence, synbiotic combinations, regulatory landscape for health claims (EFSA, FDA), and the FDA Live Biotherapeutic Products framework. Discussion addresses probiotic quality and stability through shelf life, microbiome-personalised probiotic recommendations, probiotic delivery in food matrices, postbiotic applications in infant formula, and the differentiation of food-supplement probiotics from drug-grade live biotherapeutic products.